Showing results (1-10 of 55) with videos related to
Sort By:
Pageof 6
Frontiers in Immunology|August 12, 2022
Divergent complement system activation in two clinically distinct murine models of multiple sclerosisMichael Linzey, Krista DiSano, Nora Welsh, et al.BMC Medical Imaging|November 14, 2023
High throughput method for detecting murine brain atrophy using a clinical 3T MRIMichael Linzey, Krista DiSano, Nora Welsh, et al.Neurology(R) Neuroimmunology & Neuroinflammation|February 12, 2024
CXCL10/IgG1 Axis in Multiple Sclerosis as a Potential Predictive Biomarker of Disease ActivityNora Welsh, Krista Disano, Michael Linzey, et al.Frontiers in Molecular Neuroscience|October 31, 2022
Theiler's virus-induced demyelinating disease as an infectious model of progressive multiple sclerosisSteven C Pike, Nora Welsh, Michael Linzey, et al.Neurology(R) Neuroimmunology & Neuroinflammation|December 21, 2018
Clinical utility of a molecular signature in inflammatory demyelinating diseaseAndrew R Pachner, Krista DiSano, Darlene B Royce, et al.Journal of Neuroimmunology|July 4, 2025
Network analysis of intrathecally synthesized proteins to unravel mechanisms of disease course in multiple sclerosisNora C Welsh, Krista D DiSano, Steven C Pike, et al.Biomedicines|September 23, 2022
The Brave New World of Early Treatment of Multiple Sclerosis: Using the Molecular Biomarkers CXCL13 and Neurofilament Light to Optimize ImmunotherapyAndrew PachnerJournal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 30, 2010
Role of differential expression of interferon receptor isoforms on the response of multiple sclerosis patients to therapy with interferon betaFrancesca GilliBrain, Behavior, and Immunity|March 5, 2026
Central nervous system-penetrant anti-C1q therapy reduces neuroinflammation and preserves neurological function in a model of progressive multiple sclerosisMichael Linzey, Steven C Pike, Nour-Maria Bouzid, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 4, 2008
Interferon-beta responders and non-responders. A biological approachAntonio Bertolotto, Francesca GilliPageof 6